Pfizer Inc. (NYSE: PFE) announced today positive topline results of two Phase 3 studies of TRUMENBA® (Meningococcal Group B Vaccine). One study included approximately 3,600 healthy individuals 10 through 18 years of age, and the …
In after hours trade shares of Pfizer were up 1.4% following the announcement. Pfizer is set to announce third quarter results on Tuesday, October 28 before the market open. Get the latest Pfizer stock price here.
Pfizer Inc. (NYSE:PFE) is expected to focus on the development of new ... likely speeding up its final testing and …
YTD, the company’s stock is down 3.18%. Shares of AstraZeneca (AZN) have a yield of 3.89% based on Friday’s closing price of $72.02 and the company’s annualized payout of $2.80. Shares of Pfizer (PFE) have a yield of 3.5% based on …
Pfizer Inc : Applied to United Kingdom Listing Authority to cancel standard listing of company's common stock . Will be cancelling listing of its common stock from six Swiss exchange .Effective date of cancellation is intended to be 23 …
has sent its shareholders on quite the ride this year. The cancer-drug company’s stock was down on its luck back in February, when the shares got caught up in a sweeping selloff in the biotech sector. The stock fell as low as $26.41 on …
Pfizer (NYSE: PFE) and Synthon, an international pharmaceutical company specializing in the development of complex generic medicines, announced they have entered into an agreement whereby Pfizer has acquired the exclusive …